國家衛生研究院 NHRI:Item 3990099045/15433
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 907780      在线人数 : 927
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/15433


    题名: Long dosing intervals of antiosteoporosis medications decrease national fracture risk: A nationwide population-based cohort study
    作者: Fu, SH;Yen, HK;Yang, RS;Lee, CC;Li, CY;Wang, CY
    贡献者: National Center for Geriatrics and Welfare Research
    摘要: Objective: We hypothesized that long dosing interval antiosteoporosis medications (AOMs), mainly those delivered parenterally, will guarantee higher adherence and persistence, which could help reduce fracture risk. The aim of this research was to evaluate the relationship between different dosing intervals of AOM and the subsequent fracture risk among patients newly initiated AOM therapies. Methods: It is a nationwide population-based cohort study based on Taiwan’s National Health Insurance Research Database. Osteoporosis patients with age C 50 who newly initiated AOM during 2008–2018 (n = 336,229) were included. We categorized AOMs into short dosing intervals (oral AOMs) or long dosing intervals (parenteral AOMs). The adherence and persistence of treatment by medication possession ratio (MPR) and subsequent fracture after treatment for 3 years were measured. Results: Among patients who initiated parenteral AOMs, the percentage of patients with high adherence (MPR C 75%) increased from 33% in 2008 to 69% in 2018. However, among patients who initiated oral AOMs, the percentage of high adherence remained stable (30%) between 2008–2018. The use of parenteral AOMs increased from 1% in 2008 to 62% in 2018. At the same time, the percentage of high adherence of those initiated AOMs significantly increased from 34% in 2008 to 61% in 2018. The risk of subsequent fracture decreased significantly between 2008–2018 after controlling for all potential confounders (hazard ratio = 0.85, 95% CI = 0.81–0.89). Conclusion: AOMs with long dosing intervals not only increased adherence and persistence but also decreased the subsequent fracture risk at a nationwide scale.
    日期: 2023-07-21
    關聯: Aging Clinical and Experimental Research. 2023 Jul 21;35:S143.
    Link to: http://dx.doi.org/10.1007/s40520-023-02442-7
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1594-0667&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:001058500201016
    显示于类别:[王貞予] 會議論文/會議摘要

    文件中的档案:

    档案 大小格式浏览次数
    ISI001058500201016.pdf70KbAdobe PDF39检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈